Patent granted for new technology diagnosing cancer

January 5, 2015 by Malene Løvig Nielsen, Aarhus University
Behind the new technology, which can be performed in most of diagnostic laboratories, is honorary associate professor Tomasz K. Wojdacz and associate professor Lise Lotte Hansen.

A new diagnostic technology may significantly improve early detection and treatment of cancer and other diseases. Via a simple blood test the method can potentially diagnose diseases such as cancer at an early stage, enable screening of healthy individuals at risk of developing cancer, and help plan an individual course of treatment. Aarhus University has just received a patent for the technology in the USA.

"The fact that we have now received for the American market is a really promising sign. We have just begun for and the first results are very encouraging. We already know that the method can be used for many different types of cancer and potentially other diseases, but carrying out research that aims to develop diagnostic testing requires substantial funding," says Tomasz K. Wojdacz, honorary associate professor at the Department of Biomedicine at Aarhus University, who together with Associate Professor Lise Lotte Hansen conducts research in the field of epigenetics with focus on DNA methylation.

"Now with the patent granted we hope to be able to find interested investors, which would speed up our research. The funding unfortunately is highly significant for how quickly the test can be implemented in hospitals around the world," says Tomasz K. Wojdacz.

A method with great potential

The new method can easily be implemented in practice. Diagnostic tests based on the method can be performed in most of diagnostic laboratories, as they do not require special equipment.

"The method detects specific changes affecting the pattern of genes, which are either active or silenced in a specific cell. The method is very sensitive and able to detect these changes in a limited number of cells, which is e.g. crucial for early diagnosis of cancer. It is well established that environmental factors play a role in changing this pattern of active and silenced genes, changes that may play a role in the onset of not only cancer but a long list of diseases including diabetes, cardiovascular and psychiatric diseases. Therefore, we see a huge potential for the use of the method we have developed," explains Lise Lotte Hansen.

Lise Lotte Hansen and Tomasz K. Wojdacz are currently focusing on the application of the method in screening and treatment but hope to soon be able to start clinical research targeting other types of cancer and diseases.

Clinical research for breast cancer has begun

Of all the countries in the world, Denmark is the one with the highest incidence of breast cancer. According to preliminary results, a new test based on this technology makes it possible to find about 15 per cent of the women who are at risk of breast cancer.

"Most of our research currently focuses on using the method to identify healthy individuals with increased risk of developing disease in the future. Identification of these patients before they develop disease has significant benefits not only for the patients but also for the healthcare systems. It brings significant savings, as it is always cheaper to prevent disease than treat it," says Tomasz K. Wojdacz.

The new technology was discovered by Tomasz K. Wojdacz and Lise Lotte Hansen and further developed by Tomasz K. Wojdacz in collaboration with the Peter MacCallum Cancer Centre, Melbourne, Australia. The application process for the US patent began in 2007 and was finalised this October when the patent protection was granted.

Explore further: Metal test could help diagnose breast cancer early

Related Stories

Metal test could help diagnose breast cancer early

December 9, 2014
It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early.

Screening does not shift breast cancer to earlier stages

March 4, 2014
Screening for breast cancer appeared to have a very limited effect on the occurrence of serious and aggressive cancer cases. On the other hand, it appeared to detect many more early cancer cases, cases which would otherwise ...

What to know if breast cancer runs in your family

October 7, 2014
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...

Researchers confirm whole-genome sequencing can successfully identify cancer-related mutations

December 23, 2014
UT Southwestern Medical Center cancer researchers have demonstrated that whole-genome sequencing can be used to identify patients' risk for hereditary cancer, which can potentially lead to improvements in cancer prevention, ...

New model of follow up for breast cancer patients

November 21, 2014
Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

New breast cancer classification based on epigenetics

December 10, 2014
Breast cancer is the most common in women. One in nine will suffer breast cancer over their lifetime. Progress in prevention and early detection, and the use of chemotherapy after surgery (adjuvant chemotherapy), have achieved ...

Recommended for you

Researchers discover novel mechanism linking changes in mitochondria to cancer cell death

February 20, 2018
To stop the spread of cancer, cancer cells must die. Unfortunately, many types of cancer cells seem to use innate mechanisms that block cancer cell death, therefore allowing the cancer to metastasize. While seeking to further ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.